Charterhouse cranks up process for potential Doc Generici sale

London-headquartered private equity firm Charterhouse has reportedly contacted investment banks to run a sale of Italian drugmaker Doc Generici, which could see the company valued at up to €700m. Reports from Reuters at the start of December suggested the firm had brought in LEK Consulting to advise on options for the pharmaceutical company, which it …